iTeos Therapeutics Inc.

NASDAQ: ITOS · Real-Time Price · USD
10.11
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
10.11
0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

iTeos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a 35M n/a -11.3M n/a n/a 12.6M 53.91M 19.49M 41.72M 152.52M 240.5M 104.27M n/a n/a
Cost of Revenue
n/a 324K n/a 302K 309K 303K 233K 224K 198K n/a 226K 203K 202K 180K 163K n/a 200K 126K
Gross Profit
n/a -324K -34.39M -302K 34.69M -303K -11.54M -224K -198K 12.6M 53.68M 19.28M 41.51M 152.34M 240.34M 104.27M -200K -126K
Operating Income
-83.79M -40.02M -49.33M -48.8M -14.17M -47.23M -40.15M -43.28M -42.62M -24.93M 17.38M -15.21M 3.33M 120.81M 213.52M 79.41M -29.34M -18.69M
Interest Income
6.38M 6.95M 7.66M 8.01M 7.82M 7.39M 7.84M 8.04M 8.04M 7.85M n/a 3.24M 1.06M 92K n/a n/a n/a n/a
Pretax Income
-77.06M -33.51M -36.36M -43.12M -5.76M -36.8M -30.57M -33.84M -33.07M -14.35M 22.75M -1.99M 8.44M 119.53M 224.04M 72.41M -26.46M -13.53M
Net Income
-78.73M -34.61M -43.71M -45.36M -7.13M -38.22M -30.55M -32.24M -34.3M -15.55M 20.45M 991K 5.63M 69.58M 184.87M 69.64M -26.46M -13.53M
Selling & General & Admin
10.18M 10.98M 11.81M 12.11M 12.46M 12.7M 12.14M 12.64M 13.44M 11.93M 11.1M 10.76M 11.47M 10.62M 9.6M 8.76M 15.1M 7.05M
Research & Development
57.27M 29.04M 37.52M 36.69M 36.4M 34.23M 27.78M 30.41M 29.19M 25.6M 25.42M 23.93M 26.91M 21.1M 17.39M 16.1M 14.24M 11.64M
Other Expenses
16.34M n/a n/a n/a n/a n/a n/a n/a 326K n/a -1.38M -698K -439K -745K 9.57M -8.48M 60K 240K
Operating Expenses
83.79M 40.02M 49.33M 48.8M 48.86M 46.93M 39.91M 43.06M 41.44M 37.52M 35.14M 33.99M 37.94M 30.97M 26.03M 23.37M 26.52M 13.77M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.02M n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
83.79M 40.02M 49.33M 48.8M 49.17M 47.23M 40.15M 43.28M 41.44M 37.52M 35.14M 33.99M 37.94M 30.97M 26.03M 23.37M 26.52M 13.77M
Income Tax Expense
1.67M 607K 7.36M 2.24M 1.37M 1.41M 2.36M -1.18M 1.23M 1.2M 2.29M -2.98M 2.82M 49.95M 39.17M 2.77M -119K n/a
Shares Outstanding (Basic)
43.56M 43.24M 40.47M 43.14M 39.7M 35.84M 35.84M 35.78M 35.77M 35.72M 35.61M 37.66M 37.51M 38.14M 35.2M 35.2M 35.12M 34.7M
Shares Outstanding (Diluted)
43.56M 43.24M 40.47M 43.14M 39.7M 35.84M 35.84M 35.78M 35.77M 35.72M 37.88M 37.66M 37.64M 38.14M 37.48M 37.48M 35.12M 35.09M
EPS (Basic)
-1.81 -0.8 -1.08 -1.05 -0.18 -1.07 -0.85 -0.9 -0.96 -0.44 0.57 0.03 0.15 1.82 5.26 1.98 -0.75 -0.39
EPS (Diluted)
-1.81 -0.8 -1.08 -1.05 -0.18 -1.07 -0.85 -0.9 -0.96 -0.44 0.54 0.03 0.15 1.82 4.89 1.86 -0.75 -0.39
EBITDA
-66.18M -40.02M -47.78M -47.69M -12.44M -36.5M -30.34M -33.62M -42.62M -23.63M 22.63M -15.21M 8.35M 119.46M 224.5M 72.44M -26.38M -13.41M
EBIT
-66.52M -34.01M -48.1M -47.99M -12.75M -45.48M -30.57M -33.84M -41.44M -23.85M 22.4M -14.51M 8.15M 121.56M 224.33M 72.24M -26.52M -13.77M
Depreciation & Amortization
340K 324K 322K 302K 310K 303K 233K 224K 198K 222K 226K 203K 202K 180K 163K 200K 200K 126K